CDT Equity/$CDT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About CDT Equity
CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. It has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The company's pipeline includes candidates that target autoimmune disorders, as well as idiopathic male infertility, oncology, dermatology, rare disease and animal health. It has one operating segment focused on the research and development of clinical assets.
Ticker
$CDT
Sector
Primary listing
Employees
4
Headquarters
Website
CDT Equity Metrics
BasicAdvanced
$3.6m
-
-$1,177.90
1.57
-
Price and volume
Market cap
$3.6m
Beta
1.57
52-week high
$11.00
52-week low
$0.71
Average daily volume
1.8m
Financial strength
Current ratio
0.342
Quick ratio
0.118
Total debt to equity
-10.809
Interest coverage (TTM)
-85.15%
Profitability
EBITDA (TTM)
-24.738
Management effectiveness
Return on assets (TTM)
-344.95%
Return on equity (TTM)
561.83%
Valuation
Price to book
-0.01
Price to tangible book (TTM)
-0.01
Price to free cash flow (TTM)
-0.002
Free cash flow yield (TTM)
-65,359.48%
Free cash flow per share (TTM)
-479.279
Growth
CDT Equity News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs